Research ArticleAccepted Articles
Online Patient Reported Outcome Measure (PROM) engagement is dependent on demographics and locality: findings from an observational cohort
Mark Yates, Katie Bechman, Maryam A. Adas, Hannah Wright, Mark Russell, Deepak Nagra, Ben Clarke, Joanna Ledingham, Sam Norton and James Galloway
The Journal of Rheumatology May 2023, jrheum.2021-1410; DOI: https://doi.org/10.3899/jrheum.2021-1410
Mark Yates
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Katie Bechman
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Maryam A. Adas
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Hannah Wright
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Mark Russell
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Deepak Nagra
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Ben Clarke
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Joanna Ledingham
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
Sam Norton
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
James Galloway
Patient and Public Involvement: A patient panel has been central to the design and delivery of NEIAA since its outset. The PROM collection tool was developed in conjunction with the patient panel, who expressed a desire for us to explore reasons behind PROM non-completion. This informed the need for this analysis. Transparency: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study reported. No important aspects of the study have been omitted. Funding: NEIAA is funded by HQIP. The lead author's salary is funded by grants from the British Society for Rheumatology and Versus Arthritis. Data Sharing: Data available upon application to HQIP. Declaration of Interests: JG has J.B.G. has received honoraria from AbbVie, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Pfizer, Roche and UCB. MY and BC have received honoraria from Abbvie. All other authors declare no conflicts of interest.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Online Patient Reported Outcome Measure (PROM) engagement is dependent on demographics and locality: findings from an observational cohort
Mark Yates, Katie Bechman, Maryam A. Adas, Hannah Wright, Mark Russell, Deepak Nagra, Ben Clarke, Joanna Ledingham, Sam Norton, James Galloway
The Journal of Rheumatology May 2023, jrheum.2021-1410; DOI: 10.3899/jrheum.2021-1410
Accepted manuscript
Online Patient Reported Outcome Measure (PROM) engagement is dependent on demographics and locality: findings from an observational cohort
Mark Yates, Katie Bechman, Maryam A. Adas, Hannah Wright, Mark Russell, Deepak Nagra, Ben Clarke, Joanna Ledingham, Sam Norton, James Galloway
The Journal of Rheumatology May 2023, jrheum.2021-1410; DOI: 10.3899/jrheum.2021-1410